177 related articles for article (PubMed ID: 29237835)
1. HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E.
Chikata T; Tran GV; Murakoshi H; Akahoshi T; Qi Y; Naranbhai V; Kuse N; Tamura Y; Koyanagi M; Sakai S; Nguyen DH; Nguyen DT; Nguyen HT; Nguyen TV; Oka S; Martin MP; Carrington M; Sakai K; Nguyen KV; Takiguchi M
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237835
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
[TBL] [Abstract][Full Text] [Related]
3. A strong association of human leukocyte antigen-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection.
Van Tran G; Chikata T; Carlson JM; Murakoshi H; Nguyen DH; Tamura Y; Akahoshi T; Kuse N; Sakai K; Sakai S; Cobarrubias K; Oka S; Brumme ZL; Van Nguyen K; Takiguchi M;
AIDS; 2016 Mar; 30(5):681-9. PubMed ID: 26595539
[TBL] [Abstract][Full Text] [Related]
4. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
[TBL] [Abstract][Full Text] [Related]
5. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
6. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
[TBL] [Abstract][Full Text] [Related]
7. Host-specific adaptation of HIV-1 subtype B in the Japanese population.
Chikata T; Carlson JM; Tamura Y; Borghan MA; Naruto T; Hashimoto M; Murakoshi H; Le AQ; Mallal S; John M; Gatanaga H; Oka S; Brumme ZL; Takiguchi M
J Virol; 2014 May; 88(9):4764-75. PubMed ID: 24522911
[TBL] [Abstract][Full Text] [Related]
8. Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8
Zhang Y; Murakoshi H; Chikata T; Akahoshi T; Tran GV; Nguyen TV; Gatanaga H; Nguyen KV; Oka S; Kuse N; Takiguchi M
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361435
[TBL] [Abstract][Full Text] [Related]
9. Control of HIV-1 Replication by CD8
Nguyen HT; Kuse N; Zhang Y; Murakoshi H; Maeda Y; Tamura Y; Maruyama R; Tran GV; Nguyen TV; Nguyen KV; Oka S; Chikata T; Takiguchi M
J Virol; 2022 Oct; 96(19):e0081122. PubMed ID: 36154612
[TBL] [Abstract][Full Text] [Related]
10. Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.
Kinloch NN; Lee GQ; Carlson JM; Jin SW; Brumme CJ; Byakwaga H; Muzoora C; Bwana MB; Cobarrubias KD; Hunt PW; Martin JN; Carrington M; Bangsberg DR; Harrigan PR; Brockman MA; Brumme ZL
J Virol; 2019 Jan; 93(1):. PubMed ID: 30305354
[TBL] [Abstract][Full Text] [Related]
11. Control of HIV-1 by an HLA-B*52:01-C*12:02 Protective Haplotype.
Chikata T; Murakoshi H; Koyanagi M; Honda K; Gatanaga H; Oka S; Takiguchi M
J Infect Dis; 2017 Dec; 216(11):1415-1424. PubMed ID: 28968792
[TBL] [Abstract][Full Text] [Related]
12. HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703.
Matthews PC; Adland E; Listgarten J; Leslie A; Mkhwanazi N; Carlson JM; Harndahl M; Stryhn A; Payne RP; Ogwu A; Huang KH; Frater J; Paioni P; Kloverpris H; Jooste P; Goedhals D; van Vuuren C; Steyn D; Riddell L; Chen F; Luzzi G; Balachandran T; Ndung'u T; Buus S; Carrington M; Shapiro R; Heckerman D; Goulder PJ
J Immunol; 2011 May; 186(10):5675-86. PubMed ID: 21498667
[TBL] [Abstract][Full Text] [Related]
13. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.
Leslie A; Matthews PC; Listgarten J; Carlson JM; Kadie C; Ndung'u T; Brander C; Coovadia H; Walker BD; Heckerman D; Goulder PJ
J Virol; 2010 Oct; 84(19):9879-88. PubMed ID: 20660184
[TBL] [Abstract][Full Text] [Related]
14. Critical effect of Pol escape mutations associated with detrimental allele HLA-C*15: 05 on clinical outcome in HIV-1 subtype A/E infection.
Murakoshi H; Chikata T; Akahoshi T; Zou C; Borghan MA; Van Tran G; Nguyen TV; Van Nguyen K; Kuse N; Takiguchi M
AIDS; 2021 Jan; 35(1):33-43. PubMed ID: 33031103
[TBL] [Abstract][Full Text] [Related]
15. Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
Zhang Y; Chikata T; Kuse N; Murakoshi H; Gatanaga H; Oka S; Takiguchi M
J Virol; 2022 Nov; 96(22):e0124822. PubMed ID: 36326273
[TBL] [Abstract][Full Text] [Related]
16. Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados.
Juarez-Molina CI; Payne R; Soto-Nava M; Avila-Rios S; Valenzuela-Ponce H; Adland E; Leitman E; Brener J; Muenchhoff M; Branch S; Landis C; Reyes-Teran G; Goulder P
J Virol; 2014 Sep; 88(18):10392-8. PubMed ID: 25008926
[TBL] [Abstract][Full Text] [Related]
17. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
Tsai MC; Singh S; Adland E; Goulder P
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
[TBL] [Abstract][Full Text] [Related]
18. HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.
Rajapaksa US; Li D; Peng YC; McMichael AJ; Dong T; Xu XN
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13353-8. PubMed ID: 22826228
[TBL] [Abstract][Full Text] [Related]
19. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
[TBL] [Abstract][Full Text] [Related]
20. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
